Asia · Markets & Finance · SCMP Business

China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

Published by SCMP Business · Hong Kong 1 h ago

The increasing global appeal of Chinese firms’ novel therapies has propelled the country’s rise as a biomedical powerhouse, but China has yet to produce a drug to rival all-time…

Read the full article on SCMP Business Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.scmp.com)

Also worth reading

The Economic Times

Tata Motors raises Iveco takeover offer to €14.40 per share, rules out further increase

Business Standard

China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

Share

Also worth reading

BP eyes bids under India oil, gas policy

Surviving the funding game: how timing can make or break your startup

CME feeder cattle hit 3-month peak after corn price plunge

When couples love their properties more than each other

Tata Motors raises Iveco takeover offer to €14.40 per share, rules out further increase

Nvidia-backed Firmus scraps $5 bn Australia IPO amid growing AI scrutiny